Effect of High-Dose NAC on Patients With DPN

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The aim of the current study is to evaluate the efficacy and safety of high dose oral NAC (2400 mg/day divided into two doses) as an adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in patients with type 2 diabetes suffering from diabetic peripheral neuropathy.
Epistemonikos ID: af0013972b1f498bfdb7085011853038521badb4
First added on: May 08, 2024